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An experimental Approach 
to Rigorously Assess paneth 
cell α-Defensin (Defa) mRnA 
Expression in C57BL/6 Mice
patricia A. castillo1, Eric B. nonnecke1, Daniel t. ossorio  1, Michelle T. N. tran1, 
Stephanie M. Goley  2, Bo Lönnerdal2, Mark A. Underwood3 & Charles L. Bevins  1
Abundant evidence from many laboratories supports the premise that α-defensin peptides secreted 
from Paneth cells are key mediators of host-microbe interactions in the small intestine that contribute 
to host defense and homeostasis. α-defensins are among the most highly expressed antimicrobial 
peptides at this mucosal surface in many mammals, including humans and mice; however, there is 
striking variation among species in the number and primary structure of α-defensin paralogs. Studies 
of these biomolecules in vivo are further complicated by striking variations between laboratory mouse 
strains. Herein, we report an experimental approach to determine with precision and specificity 
expression levels of α-defensin (Defa) mRNA in the small intestine of C57BL/6 mice through an 
optimized set of oligonucleotide primers for qRT-PCR assays and cloned cDNA plasmids corresponding 
to the Defa paralogs. This approach demonstrated marked differences in α-defensin expression in 
C57BL/6 mice with respect to proximal/distal anatomical location and developmental stage, which have 
not been described previously. These data underscore the importance of careful attention to method 
(primer choice, proximal vs. distal location, and developmental stage) in analysis of antimicrobial 
peptide expression and their impact.
The intestinal mucosa of mammals is a site of remarkably complex and vitally important host-microbe interac-
tions1. The intestinal tract harbors a diverse, abundant and dynamic group of microorganisms, which can have 
profound effects on host nutrition, physiology and immune response2–9. While the host derives many benefits 
from mutualistic interactions with various gut microbes, disruption of this community, termed dysbiosis, creates 
niche opportunities for the proliferative expansion of noxious organisms that compromise homeostasis and can 
cause disease9–23.
Accumulating evidence indicates that the host orchestrates mucosal homeostasis by accommodating and 
shaping the composition of contiguous microbial populations16,24–27. In the mammalian small intestine, one 
influential host factor of this ecosystem is a collection of proteins and peptides secreted by Paneth cells28–30. In 
humans, mice, and many other mammals Paneth cells are specialized epithelial cells located at the base of the 
crypts of Lieberkühn in the small intestine interdigitated between epithelial stem cells30. These secretory cells 
produce especially high quantities of antimicrobial peptides called α-defensins29–31. In mice, α-defensins were 
originally named “cryptdins” (for crypt defensins), which are orthologs of the human α-defensins HD5 (DEFA5) 
and HD6 (DEFA6)28,32. Paneth cell α-defensins are stored in cytoplasmic secretory granules together with other 
luminally delivered antimicrobials29. Secreted α-defensins function to defend the intestinal mucosa from viru-
lent microbes33,34, inhibit microbial translocation across the epithelium35 and help shape the composition of the 
colonizing microbiota24. Thus, Paneth cell α-defensins serve critically important functions in homeostasis and 
host defense.
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Mice are the most widely studied species to model acute and chronic disease36. Many valuable insights on 
enteric host-microbe interplay have stemmed from, and depend on, investigation of mouse models. Yet, while 
the in vivo dynamics of host-microbe interactions in the intestine can be profoundly influenced by Paneth cell 
α-defensins, their characterization and biological analysis have been technically challenging due, in part, to their 
extensive repertoire within and across common laboratory mouse strains. Analysis of the α-defensin gene locus 
in C57BL/6 mice identified a multitude of Defa genes, Defa-related genes and Defa pseudogenes that share very 
similar sequences37,38. The remarkable number of closely related α-defensin gene paralogs in C57BL/6 mice ren-
ders analysis of expression of individual α-defensin mRNA and protein difficult by routine quantitative reverse 
transcription-polymerase chain reaction (qRT-PCR) or antibody-based experimental approaches. Given the 
extensive reliance on C57BL/6 mice for studies probing the influence of host genetics on host-microbe interac-
tions, together with the importance of α-defensins in the intestinal ecosystem, there remains a critical need for a 
robust and rigorous approach to analyze α-defensin expression. To address this problem, Menendez, et al.39 made 
a significant initial advance for the field by identifying seven subgroups of expressed Defa genes in C57BL/6 mice. 
Isolation and structural characterization of the mature α-defensin peptides corresponding to these subgroups 
had been previously reported by others38,40. This categorization enabled Menendez et al. to develop a set of PCR 
primer pairs that could amplify each of these Defa subgroups by qRT-PCR39.
Several years ago, our laboratory developed a robust qRT-PCR approach using external cDNA standards that 
readily permits quantitative comparisons of mRNA expression for genes encoding antimicrobial peptides in tis-
sues from diverse specimens and experimental influences41. In this approach, we determine the absolute mRNA 
transcript numbers (based on external standard curves) as the primary data, not simply as a normalized ratio to a 
“housekeeping” gene (i.e., ΔΔCT)41. This approach is a bit more labor intensive, but addresses the recommenda-
tions by Bustin42, who demonstrated that normalization to “housekeeping” gene mRNA levels can compromise 
comparisons, or at times, lead to erroneous conclusions since expression levels of certain “housekeeping” genes 
(especially glyceraldehyde-3-phosphate dehydrogenase (Gapdh)) may vary by orders of magnitude among tissue 
sources, experimental conditions and/or tissue pathology42,43.
With these issues in mind, the goals of the current study were to (i) clone cDNA templates of α-defensin 
encoding mRNA subgroups in C57BL/6 mice and develop a set of external standard quantitative curves for 
RT-PCR analysis, (ii) use these Defa cDNA templates to determine the specificity of each Defa PCR primer pair 
initially reported by Menendez, et al.39 and modify the primer sequences to substantially enhance specificity, and 
(iii) use the external standard curves to determine the absolute Defa mRNA abundance in C57BL/6 mice with 
respect to several experimental parameters. The latter included expression along the small intestinal tract, during 
postnatal development, in mice with genetic knockout of the gene encoding myeloid differentiation primary 
response 88 (MyD88), and in germ-free mice, as well as in mice following streptomycin treatment. We report the 
development of an optimized set of PCR primers and cloned cDNA standards, which together provide a set of 
qRT-PCR assays that are quantitative and specific for the paralog subgroups of α-defensin genes in C57BL/6 mice 
(now expanded to eight). Using these assays, our data extend the previous reports of partial characterization of 
α-defensin gene expression in this important mouse model. Importantly, our data reveal patterns of α-defensin 
expression that vary dramatically in terms of anatomical location and developmental stage, which have not been 
previously elucidated. In addition, our results identify some key potential pitfalls that could arise from interpret-
ing data from less rigorous analytical approaches.
Results
Sequence comparisons of Defa gene paralogs in C57BL/6 mice. The α-defensin gene paralogs in 
C57BL/6 mice encode a collection of α-defensin mRNA with remarkable sequence similarity (Fig. 1A,B and 
Supplementary Fig. S1)38,40. We refined the paralog grouping proposed by Menendez, et al.39 to include eight 
subgroups (Supplementary Table S1): Defa3 (Defa3 and Defa17), Defa5 (Defa5, Defa34, Defa35, Defa36 and 
Defa37), Defa20 (Defa20, Defa32, Defa33, and Defa2), Defa21 (single member), Defa22 (single member), Defa23 
(Defa23, Defa27, and Defa31), Defa24 (Defa24 and Defa30) and Defa26 (Defa26 and Gm15292). We were able to 
establish discriminating assays for Defa21 and Defa22, yielding eight rather than the seven previously described 
subgroups39. The individual members within each group had one or more discriminating nucleotides, but in the 
case of nonsynonymous differences, the encoded amino acid differences were subtle (Supplementary Fig. S1). 
Those amino acid substitutions were generally in the signal sequence or propeptide regions, except for Defa24 
vs. Defa30 (which encode a conservative Leu/Met amino acid difference in the mature peptide), and Defa23 vs. 
Defa 27 (which encode conservative Ile/Val, Leu/Met, and Met/Ile amino acid differences in the mature peptide). 
Sequence similarity clustering (Clustal analysis) of the Defa mRNA sequences (Fig. 1B) and mature α-defensin 
peptide sequences (Fig. 1C) show nearly identical patterns for these subgroups.
Development of new quantitative assays to assess C57BL/6 Defa mRNA expression with high 
specificity. In order to quantitate the expression of each of the eight C57BL/6 Defa paralog subgroups, we 
sought to determine absolute mRNA copy number using methodology previously published by our laboratory41. 
For this approach, we first cloned cDNA for the index member of each of the C57BL/6 Defa target paralog sub-
groups in order to develop standard curves for quantitative measure and rigorous assessment of assay specificity 
(see Methods). The serially diluted standard cDNAs for each Defa subgroup were then used as templates for 
qRT-PCR amplification using the gene-specific primers (Table 1). These PCR reactions were monitored to deter-
mine the threshold of product detection for each concentration of standard template and the data were used to 
create a standard curve to extrapolate values from experimental tissue samples. In order to ascertain if the Defa 
PCR primers (Table 1) were specific for their designated target, we tested each primer pair against the full panel 
of cDNA plasmid standards at a template concentration of 105 copies per reaction (Fig. 2). Since each PCR primer 
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pair showed target specificity by amplifying only their intended cDNA target, we conclude that intended- vs. 
off-target amplification was ≥105-fold in each case.
For analysis of most target genes, selection of PCR primers from adjacent exons allows easy discrimination 
of amplification from cDNA vs. (contaminating) genomic DNA templates, since genomic DNA will require less 
efficient amplification across an intron; however, the high sequence similarity of the Defa mRNA transcripts 
Figure 1. Sequence comparisons of C57BL/6 Defa mRNA and mature peptides. (A) Sequence alignment 
of eight Defa mRNA paralogs in C57BL/6 mice. The eight Defa mRNA paralogs are index members of the 
subgroups whose sequence alignment is presented in Supplementary Fig. S1. Accordingly the subgroups are: 
Defa3 (Defa3 and Defa17), Defa5 (Defa5, Defa34, Defa35, Defa36 and Defa37), Defa20 (Defa20, Defa32, Defa33, 
and Defa2), Defa21 (single member), Defa22 (single member), Defa23 (Defa23, Defa27, and Defa31), Defa24 
(Defa24 and Defa30) and Defa26 (Defa26 and Gm15292). A high degree of sequence similarity uniformly 
distributed across coding and untranslated regions are evident. (B) Clustal similarity dendrogram of Defa 
mRNA sequences. NCBI accession numbers from sequences used in this analysis are listed in Supplementary 
Fig. S1. (C) Clustal similarity dendrogram of Defa mature peptide sequences. Sequences are from the 
literature38,40. Clustal analysis was performed by MacVector software using an unweighted pair group method 
with arithmetic mean.
Gene 
Target Primer Sequence
Product 
Length
(BP)
Annealing 
Temp
(°C)
Reference
or
Source
Defa3 F: ATCTGGTATGCTATTGTAGAAAR: GTGGCCTCAGTACTCATGT 147 62 this work
Defa5 F: TCAAAAAAGCTGATATGCTATTGR: AGCTGCAGCAGAATACGAAAG 106 58
F: ref.39
R: this work
Defa20 F: GAGAGATCTGATATGCTATTGR: AGAACAAAAGTCGTCCTGAG 86 62
F: this work
R: ref.39
Defa21 F: GAGAGATCTGATCTGCCTTTGR: CCTCTATTGCAGCGACGA 45 64
F: ref.39
R: this work
Defa22 F: AGCAGCCAGGGGAAGAGR: CCTCTATTGCAGCGACGT 124 64 this work
Defa23 F: TCTGGTATGCTATTGTAGAACR: GACAGCAGAGCGTGTATA 95 62 this work
Defa24 F: GATCTGGTATGCTATTGTAGAGR: GACAGCAGAGCATGTACAA 97 64 this work
Defa26 F: ATTGTAGAAAAAGAGGCTGTACR: AGCAGAGTGTGTACATTAAATG 81 62 ref. 
39
Table 1. Oligonucleotide primer sequences used for qRT-PCR analysis of α-defensin (Defa) gene expression 
in C57BL/6 mice. PCR reaction conditions were 95 °C for 5 min, followed by 45 cycles of: denaturation at 95 °C 
for 20 sec, annealing for 20 sec at the temperature specified, and extension at 72 °C for 30 sec. As indicated, the 
sequences were either from this study or Menendez, et al.39. F (forward/sense primer), R (reverse/antisense 
primer).
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(Fig. 1) limited the selection possibilities for discriminatory gene-specific primers. Therefore, the PCR primer 
pairs for all except Defa22 were located within a single exon, giving rise to the possibility that trace contami-
nating genomic DNA could affect estimates of Defa mRNA expression at sites with low Defa gene expression 
(Supplementary Fig. S2). To examine this potential caveat, we treated isolated RNA specimens from colon, a 
tissue with negligible Defa gene expression, with DNase prior to cDNA synthesis. The apparent trace expression 
in the colon for Defa3, Defa5 and Defa21 (<10e3 mRNA copies per 10 ng mRNA) was eliminated by DNase 
treatment (Supplementary Fig. S2). In parallel, estimates of beta-actin (Actb) expression, whose PCR primer pair 
spanned an intron (Table 2), did not change after DNase treatment of the colonic RNA supporting that the DNase 
treatment did not affect the quality of the RNA used in the analysis (Supplementary Fig. S2). Since Defa expres-
sion in the colon was either decreased or undetectable following DNase treatment, we conclude that the apparent 
low-level expression without DNase treatment is erroneous, and likely due to trace genomic DNA contamination 
of the isolated RNA specimens. By contrast, analysis of distal small intestine where Defa expression was abundant, 
showed DNase treatment had no detectable effect on estimates of Defa expression values (Supplementary Fig. S2). 
These control experiments highlight that caution is needed when interpreting and reporting low level mRNA 
expression (≤10e3 mRNA copies per 10 ng mRNA) using most primers in Table 1. Our data indicate that either 
intron-spanning PCR primer pairs (Defa22) and/or DNase pretreatment of RNA is warranted to draw rigorous 
conclusions on low-level expression. Several additional control experiments for rigor and reproducibility of this 
qRT-PCR experimental approach are described in the Materials and Methods, and others were reported by our 
group previously41.
Anatomical expression of Defa mRNAs in the adult C57BL/6 mouse small intestine. Previous 
studies with FVB and BALB/c mice show regional variations for expression of some Paneth cell α-defensin genes 
in the small intestine44–46. In particular, cryptdin 444–46 and the cryptdin-related sequence 4c (Crs4c/Defcr-rs10)46 
had higher expression in the distal small intestine (ileum) compared to more proximal sites. However, C57BL/6 
mice do not express either cryptdin 4 or Crs4c40,47 and regional analysis of expression for other α-defensin genes 
is lacking. Therefore, we sought to determine quantitatively the anatomical expression of each Defa gene in adult 
Figure 2. Analysis of specificity for the Defa qRT-PCR primer pairs. The eight pairs of Defa-targeting 
oligonucleotide primer pairs (Table 1) were used to amplify each of the eight plasmid cDNA standards present 
at 105 copies per each reaction tube. Each panel of data represents reactions using the single pair of PCR primers 
indicated, and the x-axis identifies the cloned cDNA templates used in the eight reactions. The plasmid cDNA 
standards were cloned, sequenced, and quantitated as described in the methods.
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C57BL/6 mouse small intestine by analyzing adjacent 3 cm sections along the proximal to distal axis, giving a total 
of ten sections (Fig. 3A). Absolute quantities of each Defa mRNA were determined by the qRT-PCR approach 
outlined above. The data from this analysis (Fig. 3B,D) yielded several interesting findings. Defa3, Defa5, Defa23, 
Defa24 and Defa26 expression were relatively uniform along the tract (Fig. 3D). Among these, Defa24 showed 
remarkably high expression (5 × 106–1 × 107 mRNA copies per 10 ng mRNA) in all sections throughout the small 
intestine (Fig. 3D,E). Defa3, Defa5 and Defa23 were also abundant, but about 5-fold less than Defa24 (Fig. 3B,D). 
In contrast to the uniform expression of those Defa genes, Defa20, Defa21 and Defa22 mRNA expression showed 
marked regional differences, with dramatically higher expression (approximately 100-fold) in the distal sections 
(Fig. 3B). Defa26 was found to be the least abundant among the α-defensin mRNA at all locations (Fig. 3D,E). 
The patterns of expression for Defa mRNA parallel the sequence similarity clustering (Clustal analysis) of mRNA 
(Fig. 1B) and mature α-defensin peptide sequences (Fig. 1C) highlighting sequence associated patterns of 
expression.
Expression of other host-microbe related genes in the small intestine were also analyzed in the ten sections, 
including regenerating islet-derived 3 gamma (Reg3g), the two lysozyme paralogs (Lyz1 (“Paneth cell”) and Lyz2 
(“macrophage”), matrix metalloproteinase-7 (Mmp7, the α-defensin processing enzyme in mice33,34), and the 
nucleotide-binding oligomerization domain containing protein 2 (Nod2, which recognizes intracellular pepti-
doglycan), as well as control genes Actb and the apical sodium-dependent bile acid transporter (Slc10a2). All 
of these genes, except Slc10a2 were expressed at a relatively constant level along the small intestine (Fig. 3F). 
Previous studies by others established that Slc10a2 is expressed much more prominently in the distal small intes-
tine, compared to proximal sites48. The qPCR expression data for Slc10a2 obtained here (Fig. 3F) reflected that 
pattern and served as a control to verify the proximal/distal orientation of the intestinal sections.
Defa expression levels were very similar across the first 3–4 proximal sections; likewise, the most distal 3–4 
sections showed similar levels of Defa expression (Fig. 3B,D). To simplify subsequent analysis of anatomic expres-
sion, we decided to analyze 10 cm of the most proximal and 10 cm of the most distal segments of small intestine. 
Consistent with data in Fig. 3, Defa3, Defa23, Defa24 and Defa26 were expressed at similar levels in the proximal 
and distal small intestine (Fig. 4A), while the differentially expressed Defa mRNA were more abundant in the 
distal region (Fig. 4B). Thus, Defa5 mRNA is 10-fold more abundant, whereas Defa20, Defa21 and Defa22 are 
100-fold more abundant in distal sections. In the proximal small intestine, Defa mRNA expression was dom-
inated by Defa3, Defa5, Defa23, Defa24, whereas in the distal region the relative Defa mRNA expression was 
more proportionately distributed (Fig. 5A). The sum (total) number of Defa transcripts in the distal intestine 
was ~5-fold higher than in the proximal small intestine (Fig. 5F). No significant differences were detected when 
comparing data from male and female mice (data not shown).
Defa expression in germ-free and antibiotic treated mice. As compared to conventional mice, mice 
reared under germ-free conditions have profound alterations in both their innate and adaptive immune sys-
tems49–52. For example, the expression of Reg3g in the small intestinal epithelium of ex-germ-free mice is mark-
edly induced (~10- to 100-fold) upon colonization with a conventional microbiota through a MyD88-dependent 
mechanism35,46,53. Previous studies have indicated that expression of Paneth cell α-defensins has less dependence 
(~2- to 10-fold) on the presence of a conventional microbiota40,45,46,53,54. Using our quantitative approach, the 
absolute copy number of each Defa mRNA was determined in 10 cm sections of the proximal and distal small 
intestine of adult C57BL/6 mice (Fig. 5). When examining the total abundance of Defa mRNA there were signif-
icantly fewer Defa transcripts (~25-fold) in the small intestine of germ-free mice at both the proximal and distal 
sites compared to conventionally housed controls (Fig. 5E,F). The relative pattern of abundance of individual Defa 
mRNA in the proximal and distal small intestine appeared similar to that of untreated control mice (Fig. 5A,B). 
By weighted PCoA, Defa expression in germ-free mice clustered away from controls, owing to differences in 
absolute expression levels (Fig. 5I,J). We conclude that Defa mRNA levels are significantly lower in both the 
proximal and distal small intestine of germ-free mice, but that the relative pattern of Defa expression is similar. 
In control experiments, expression of Reg3g in the conventional mice was at levels comparable to Actb, whereas 
Gene Primer Sequence
Product 
Length
(BP)
Annealing 
Temp
Reference/
Source
Actb F: GCTGAGAGGGAAATCGTGCGTGR: CCAGGGAGGAAGAGGATGCGG 99 58 ref.
77
Lyz1 F: GCCAAGGTCTACAATCGTTGTGAGTTGR: CAGTCAGCCAGCTTGACACCACG 86 58 ref.
77
Lyz2 F: GGCTGGCTACTATGGAGTCAGCCTGR: GCATTCACAGCTCTTGGGGTTTTG 177 58 ref.
46
Nod2 F: CGACATCTCCCACAGAGTTGTAATCCR: GGCACCTGAAGTTGACATTTTGC 123 58 ref.
77
Mmp7 F: TTCAAGAGGGTTAGTTGGGGGACTGR: TTGTCAAAGTGAGCATCTCCGCC 152 58 ref.
46
Slc10a2 F: TTGCCTCTTCGTCTACACCR: CCAAAGGAAACAGGAATAACAAG 107 58 this work
Table 2. Oligonucleotide primer sequences used for qRT-PCR analysis of gene expression in C57BL/6 mice. 
The primer target sequences were in exons so as to span an intron in the genomic sequence. PCR reaction 
conditions were 95 °C for 5 min, followed by 45 cycles of: denaturation at 95 °C for 20 sec, annealing for 20 sec at 
58 °C, and extension at 72 °C for 30 sec. F (forward/sense primer), R (reverse/antisense primer).
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in the germ-free animals Reg3g expression was lower by approximately 10- to 100 fold (Supplementary Fig. S3), 
consistent with previous reports46,53,55,56.
Since mice are routinely orally gavaged with streptomycin before oral challenges with pathogens such as S. 
Typhimurium to overcome microbiota-mediated resistance to infection57–60, we sought to determine if strepto-
mycin treatment modulated Defa mRNA expression. Adult C57BL/6 mice were orally gavaged with streptomycin 
(1 mg/g body weight), which is a typical protocol prior to inoculation with enteropathogens. After four days, the 
Figure 3. Absolute quantification of Defa mRNA in adjacent sections along the small intestinal tract of wild 
type C57BL/6 mice. (A) Image depicts the most proximal to the most distal sections (3 cm each) of small 
intestine procured for analysis. (B,D) Quantitative RT-PCR analysis and (C,E) relative percent of each mouse 
Defa mRNA gene analyzed in tissue in 3 cm sections from the most proximal to most distal small intestine. (F) 
Quantitative RT-PCR analysis of other Paneth cell products and control genes in 3 cm sections from the most 
proximal to the most distal small intestine. PCR oligonucleotide primers were described in Table 1 (for panels 
B,D) and Table 2 (for panel F). The error bars represent standard error of the mean, N = 4 mice.
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absolute copy number of each Defa mRNA was determined in 10 cm sections of the proximal and distal small 
intestine. No statistically significant differences in Defa mRNA expression were detected in streptomycin-treated 
mice compared to untreated control mice in terms of total abundance of Defa mRNA in either the proximal or 
distal small intestine (Fig. 5G). The relative abundance pattern of the Defa mRNA (Fig. 5C) was similar and on 
weighted PCoA plots, the data points for the specimens from streptomycin-treated mice cluster with untreated 
controls in both the proximal and distal small intestine (Fig. 5I,J). Thus, while Defa mRNA expression varies 
when comparing germ-free to conventional mice, expression patterns are resilient to less profound transient 
perturbations in luminal microbes.
Defa expression in MyD88 knockout mice. MyD88 is an adaptor protein required for signaling from 
the TLR/IL-1 family of receptors. The expression of Reg3g in the small intestine is critically dependent on this 
biomolecule35,53,61. A previous study reported that MyD88 deficient mice had significantly lower expression of 
all Defa genes (3- to 20-fold) in the distal small intestine39, whereas others reported no significant differences in 
small intestinal Defa gene expression in MyD88 deficient compared to controls61. In the present study, absolute 
copy number of each Defa mRNA was determined in both the proximal and distal small intestine of MyD88 
knockout mice (Fig. 5D,H). No statistically significant differences in Defa mRNA expression were detected in 
MyD88 knockout mice compared to control C57BL/6 mice. Thus, the total abundance of Defa mRNA in the prox-
imal and distal small intestine was indistinguishable from control mice (Fig. 5H), the relative abundance pattern 
for the Defa mRNA transcripts (Fig. 5D) was similar, and data points from the MyD88 knockout cluster with data 
points from control wildtype mice on weighted PCoA plots (Fig. 5I,J). Consistent with previous reports35,55,61,62, 
expression of Reg3g in both the proximal and distal small intestine was approximately 10- to 100-fold lower in 
MyD88 knockout mice compared to wildtype controls (Supplementary Fig. S3).
Dynamics of Defa gene expression during postnatal development of C57BL/6 mice. Previous 
studies using outbred Swiss mice, and inbred FVB and BALB/c mice have shown that Defa genes can be detected 
in neonatal small intestinal tissue and that their expression increases until adulthood45,63–65. To address how small 
intestinal expression of the Defa genes change during development using our qRT-PCR approach, we isolated 
samples of proximal and distal small intestine from pre-weanling (postnatal days 5, 10, and 20) and adult (post-
natal day 50) mice. In both proximal and distal small intestine, collective transcript levels of Defa genes increased 
from postnatal days 5 to 50 reaching levels of 105–107 copies per 10 ng RNA in proximal and distal small intes-
tine, respectively (Fig. 6A). The increased abundance was most marked from days 20 to 50 for all Defa genes. 
Increased expression was also observed when comparing days 5 to 10 for all Defa genes with the exception of 
Defa24 and Defa3. More modest changes for all Defa genes were observed between postnatal days 10 and 20. 
Similar to the Defa genes, Reg3g, and Lyz1 (Paneth cell lysozyme) exhibited increased expression from postnatal 
day 5 to 50, with Reg3g showing high expression that plateaued by postnatal day 20 (Fig. 6B). However, the mag-
nitude of change was lower for both Reg3g and Lyz1 (~10-fold) compared to the Defa genes (~100-fold), in both 
proximal and distal small intestine. Little change in Reg3g and Lyz1 expression was detected in the colon during 
Figure 4. Quantitative comparison of Defa mRNA expression in proximal and distal small intestine of wildtype 
C57BL/6 mice. Quantitative real-time PCR analysis showing absolute quantification of each mouse Defa mRNA 
analyzed in tissue from the most proximal (left bars) and distal 10 cm sections (right bars) of the small intestine 
of wild type C57BL/6 mice. (A) Expression of Defa3, Defa5, Defa23, Defa24 and Defa 26 paralog groups which 
have less pronounced anatomic expression differential. (B) Expression of Defa20, Defa21 and Defa 22 paralog 
groups which have greater anatomic expression differential. The error bars represent standard error of the mean. 
A Mann-Whitney test was used for non-parametric statistical analysis (p values less than 0.05 were considered 
significant, N = 4 mice).
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development (Supplementary Fig. S4). The expression of Actb mRNA was relatively consistent at all anatomic sites 
and independent of age.
Discussion
Paneth cell α-defensins mediate critically important functions for the intestinal ecosystem, including helping to 
shape the composition of the colonizing microbiota, as well as protecting the host from food and water-borne 
pathogens28–30. Determining expression levels of α-defensins can be experimentally challenging, in part, because 
the significant variation in sequence between mammalian species requires species-specific reagents. Special chal-
lenges are encountered with investigations of mice, the most commonly utilized laboratory model for probing 
host-microbe interaction. Owing to extensive gene duplication in the defensin gene locus, common laboratory 
mouse strains harbor exceptionally variable collections of α-defensin gene paralogs, often with high sequence 
similarity37,38,40,66. Together these features make the design of discriminating assays difficult. Our approach uses 
a collection of cloned external standards that permit not only quantitative measure, but also provide a means 
Figure 5. Expression of Defa mRNAs in the small intestine C57BL/6 mice. Quantitative real-time PCR 
analysis showing relative percent of each mouse Defa mRNA expressed (A–D) and an arithmetic sum of all 
Defa transcripts detected (E–H) in the most proximal and distal 10 cm tissue sections of the small intestine of 
(A,E) wild type control, (B,F) germ-free, (C,G) streptomycin treated and (D,H) MyD88 gene knockout mice. 
Weighted principle component analysis of data from A-D for the most proximal (I) and distal (J) 10 cm sections 
of the small intestine. For E-H, the error bars represent standard error of the mean. A Mann-Whitney test 
was used for non-parametric statistical analysis (p values less than 0.05 were considered significant, N = 4 for 
untreated and MyD88, N = 3 for streptomycin, and N = 5 for germ-free). *p < 0.05, **p < 0.01.
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to directly assess assay specificity. The PCR primer pairs developed here (Table 1) for the qRT-PCR assays were 
initially based on those reported by Menendez39. Our panel of cDNA clones for each of the eight target Defa sub-
groups enabled meticulous optimization of the primer pairs used in this study, which provided target specificity 
of ≥105-fold compared to off-target PCR amplification (Fig. 2).
One of the important findings reported here is the anatomic distribution of expression along the length of the 
small intestine (Fig. 3), yielding several notable expression patterns: (i) The total abundance of Defa mRNA was 
lower in the most proximal sections; (ii) Defa24 and Defa20 were the most abundant mRNA in any of sections; 
Figure 6. Expression of Defa mRNA in the small intestine during development of C57BL/6 mice. (A) 
Quantitative RT-PCR analysis of Defa mRNA and (B) other Paneth cell products and control genes analyzed in 
the most proximal 10 cm to the most distal 10 cm sections of the small intestine in post-natal day 5, 10, 20 and 
50. Error bars represent standard error of the mean, N = 4 mice. (C) Weighted principal component analysis of 
Defa mRNA levels in the most proximal and distal 10 cm of the small intestine on postnatal day 10, 20, 50.
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(iii) Expression of Defa20, Defa21 and Defa22 mRNA was dramatically (~100-fold) increased in the more distal 
segments. These regional expression differences are consistent with data from previous studies in outbred Swiss 
mice44, and inbred 129/Sv65, BALB/c45 and FVB mice46, as well as a recent study using single-cell RNA sequence 
analysis of small intestine in C57BL/6 mice67. Higher Defa mRNA expression in the distal small intestine could 
not be attributed solely to numbers of Paneth cells per crypt, which are higher distally by only about 3-fold63,68.
An important practical point regarding experimental reproducibility and rigor should be emphasized. Because 
of the substantial variation in expression of Defa genes along the small intestinal tract, careful sample procure-
ment is critically important in experiments aimed to assess Defa mRNA abundance between treatment groups. 
For example, estimates of Defa20, Defa21 and Defa22 mRNA levels could erroneously appear to vary significantly 
as a result of experimental manipulation, while measured differences could be, in fact, dependent solely on impre-
cise anatomic sampling since expression levels vary in proximal vs. distal sections ~100- to 1000-fold.
Whereas this investigation focused on small intestinal α-defensin gene expression assessed at the mRNA 
level, the expression data reported here are supported by previous investigations from two laboratories reporting 
the isolation and characterization of the small intestinal α-defensin peptides from C57BL/6 mice38,40, including 
studies of in vitro antimicrobial activity38. Of note, the α-defensins showing the striking pattern of much higher 
mRNA expression in the distal small intestine, Defa20, Defa21, and Defa22 (Figs 3 and 4), encode mature peptides 
with distinguishable features in primary structure (Fig. 1 and Supplementary Fig. S5). These α-defensins have 
extended C-termini containing multiple cationic amino acid residues and a reduction in the distance between 
disulfide-participating Cys(IV) and Cys(V) by three amino acid residues (Supplementary Fig. S5)38,40. The over-
all sequence of mature Defa20, Defa21, and Defa22 peptides are more similar with one another, and differ in 
sequence from the other five mature α-defensins (Fig. 1 and Supplementary Table S2). These latter five (Defa3, 
Defa5, Defa23, Defa24 and Defa 26) are more similar with one another than the others and more uniformly 
expressed. It is likely that the marked differences in expression of the structurally dissimilar α-defensins along the 
small intestine have implications on their protective and/or homeostatic functions. Genomic sequence analysis 
using ClustalW nucleotide alignments and Pustell matrix blots could not readily discriminate between these two 
groups (Supplementary Fig. S6), leaving the mechanism for differential gene expression an open question.
Another notable change in Defa gene expression reported here is the pattern during postnatal development, 
with most notable increases detected for all eight subgroups of Defa genes when transitioning from postnatal day 
20 (weaning period) to adult mice (Fig. 6). The transcript levels of Defa genes increased ~10- to 100-fold during 
this developmental window, whereas Reg3g, Lyz1 (Paneth cell lysozyme), and Mmp7 expression levels increased 
modestly (~5- to 10-fold) during this developmental window. The numbers of Paneth cells per crypt in this devel-
opmental window of C57BL/6 mice increase from 3–4 per crypt in the days prior to weaning to 5–6 per crypt in 
the weeks after weaning69,70, so much of the observed increase in mRNA levels is attributable to increased gene 
expression. These changes in gene expression during development in C57BL/6 mice are in-line with previous 
studies using outbred Swiss, and inbred FVB and BALB/c mice45,46,63–65. The high incidence of bacterial diarrhea 
as a cause of mortality in newborns and young children is likely due to developmental immaturity of the innate 
immune system, possibly including α-defensins.
Compared to conventionally reared control mice, the collective total abundance of Defa transcripts was lower 
(~25-fold) in the small intestine of germ-free mice at both the proximal and distal sites (Fig. 5). The numbers of 
Paneth cells per crypt in germ-free mice is modestly lower than in controls (4.1 vs. 6.4 per crypt, respectively)69, 
so much of the observed difference in mRNA levels is attributable to gene expression. These data are in line 
with previous studies probing the effects of a germ-free environment on quantitative expression of Paneth cell 
α-defensins in BALB/c, NMR/KI, 129/Sv and outbred Swiss mice40,45,46,54. Whereas chronic exposure to antibiot-
ics affects Defa expression39, the more subtle and transient perturbations in microbiota associated with the com-
monly employed oral gavage with streptomycin71 in conventionally reared control mice resulted in no perceptible 
change in α-defensin expression (Fig. 5), although transient subtle alterations at other timepoints cannot be ruled 
out. In a previous study of C57BL/6 mice with more prolonged antibiotic exposure (streptomycin (450 mg/l) in 
drinking water for four days), decreased expression of Defa5 (2-fold), Defa20 (30-fold) and Defa23 (4-fold) in the 
distal small intestine were reported39.
We also report data addressing a controversial issue in the literature on Defa expression in MyD88 deficient 
C57BL/6 mice. Our determination of absolute copy number for each Defa mRNA in both the proximal and distal 
small intestine of MyD88 knockout mice compared to wildtype controls found no significant differences (Fig. 5). 
As a control, our analysis of expression of Reg3g in both the proximal and distal small intestine showed approx-
imately 10- to 100-fold lower mRNA levels in MyD88 knockout mice compared to controls (Supplementary 
Fig. S3), consistent with several published reports35,55,61,62. Thus, our data on Defa expression in MyD88 deficient 
C57BL/6 mice are in line with the results of Stockinger, et al.61, rather than an earlier report of significantly lower 
Defa gene expression in the distal small intestine of MyD88 deficient mice39.
qRT-PCR is a widely utilized method of determining mRNA expression levels and the approach reported here 
should aid in investigations of host-microbe dynamics in C57BL/6 mice. We concur with the recommendation of 
Bustin42 that housekeeping gene expression levels should be reported relative to total tissue RNA, rather than as 
a normalizing denominator (i.e., ΔΔCT). When values for target gene mRNA levels are normalized to a house-
keeping gene information is lost, comparisons between experiments are compromised and erroneous results 
can stem from differences in housekeeping mRNA levels that might vary among different tissues or with disease 
status42,43. However, even if the oligonucleotide PCR primers of Table 1 are used in qRT-PCR assays relying on 
control gene expression (i.e., ΔΔCT) rather than the more elaborate external standard comparators used here, 
specificity of target Defa gene assessment is still possible in C57BL/6 mice. A caveat must be noted, however. 
Because of the extensive nucleotide similarity within the Defa mRNA of C57BL/6 mice (Fig. 1), the discriminat-
ing PCR primer pairs that were selected and optimized for this study (Table 1) were contained within a single 
exon, except for the intron-spanning pair targeting Defa22. As highlighted in Supplementary Fig S2, when using 
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the primer pairs that do not span an intron, DNase treatment of RNA prior to cDNA synthesis is warranted in 
order to draw to draw rigorous conclusions on Defa mRNA levels in extra-small intestinal tissues (e.g., colon) 
with low-level expression (that is, ~10e3 mRNA copies or less per 10 ng mRNA with external standards, or with 
relative levels of ~0.001 or less compared to Actb expression).
In summary, the methodological approach reported here utilizes external standards and generates assessment 
of absolute concentrations of specific α-defensin mRNA in experimental tissues. The approach overcomes the 
technological challenge of highly similar α-defensin paralogs in C57BL6 mice and offers a rigorous means to 
compare Paneth cell α-defensin mRNA expression in investigations in separate laboratories. In some circum-
stances, simply using the oligonucleotide primers and conditions presented in Table 1, together with being mind-
ful of the anatomic and developmental expression patterns elucidated here, should provide investigators with 
higher confidence of rigor in data interpretation.
Methods
Mice. The Institutional Animal Care and Use Committee at the University of California, Davis, approved all 
procedures involving live animals and methods of euthanasia; experiments were performed in accordance with 
these approved procedures. The genetic background of all mice used in these experiments was C57BL/6. Dr. 
Andreas Bäumler and members of his laboratory generously provided small intestinal tissue (Figs 4 and 5) from 
germ-free (Taconic Biosciences, Germantown, NY), streptomycin-treated72 and MyD88−/− mice73. Tissues for 
experiments of Figs 3 and 6 were from a specific-pathogen free mouse colony at UC Davis.
RNA isolation and reverse transcription. The general procedures for RNA isolation and synthesis of 
cDNA were previously described by our group41. Briefly, intestinal tissue samples were dissected immediately 
after mice were euthanized and placed in RNAlater (~1:10 w/v, Sigma Aldrich, St. Louis, MO). The RNAlater 
specimen tubes were incubated with gentle rocking overnight at 4 °C, and then stored at −20 °C. For process-
ing, the RNAlater solution was decanted and the tissue was homogenized in guanidine thiocyanate buffer41,74. 
Total RNA was isolated using cesium chloride gradient ultracentrifugation41, and then quantified using ultra-
violet absorption spectrometry at 260 nm. For cDNA synthesis, 1 to 5 µg of total RNA was reverse transcribed 
using Superscript II reverse transcriptase (Invitrogen, Carlsbad, CA) using an oligo- (dT)12–18 primer41. The 
single-stranded cDNA product was purified using Qiagen PCR purification kit (Qiagen, Valencia, CA), and 
diluted to 10 ng/µl based on the input concentration of total RNA. Previous control experiments by our group 
demonstrated that when RNA from a single specimen was used to independently synthesize, isolate and purify 
the cDNA, the reaction-to-reaction variability was ≤ 15%41. Other reproducibility assessments of this approach 
were previously reported41.
In experiments to interrogate the possible role of contaminating DNA as confounding factor in qRT-PCR 
assays, total RNA (1 µg) was treated with DNase I (1 units, Thermo Fisher Scientific, Waltham, Massachusetts) 
for 30 minutes at 37 °C and then the enzyme was inactivated according to the manufacturer’s suggestions. The 
resulting RNA sample was used as a template for reverse transcription as described above.
For analysis of expression during development, intestinal tissues were isolated at postnatal day (PD) 5, 10, 20, 
and 50. Immediately after euthanasia, the intestine was flushed with PBS to clear luminal contents. For PD5, PD10 
and PD20, the small intestine was then sectioned equally into proximal and distal portions and then processed as 
above. For PD 50 (adult) mice, 10 cm of the most proximal small intestine, 10 cm of the most distal small intestine, 
the proximal half of the large intestine and the distal half of the large intestine were dissected, and then processed 
as above.
Generation of Defa standard curves. Primers that target C57BL/6 Defa mRNA (Supplementary Table S3) 
were designed to amplify the collection of Defa cDNAs from small intestinal mRNA in four reactions, each yield-
ing mixed PCR products. The PCR reaction conditions were 95 °C for 5 min, followed by 35 cycles of 95 °C, 
30 sec, annealing for 30 sec at 58 °C and extension at 72 °C for 90 sec. Final extension time was 7 min at 72 °C. The 
resulting PCR product pools were then ligated into a pBluescript II s/k plasmid vector (Agilent Technologies, 
Stratagene Products Division, La Jolla, CA)75,76 and transformed into E. coli cells. Multiple clones from each PCR 
reaction were isolated and the plasmid DNA from the clones was purified and sequenced in both directions to 
determine the identity of each clone. This yielded eight targeted Defa cDNAs for use as external standards (Defa3, 
Defa5, Defa20, Defa21, Defa22, Defa23, Defa24, and Defa26). The Defa specific plasmids were then quantified by 
UV spectroscopy, the molar concentration of each Defa cDNA insert determined, and then 10-fold serial dilu-
tions were performed using yeast RNA (0.2 µl/µl) as a carrier nucleic acid in the diluent. These dilutions provided 
templates used in real-time PCR with gene-specific PCR primers (Table 1) in order to generate standard curves 
for each reaction41. Using Avogadro’s constant, the number of Defa target sequence copies were calculated for 
each of the standard curve solutions. The Defa gene-specific PCR primer pairs for the eight target cDNAs were 
designed, based initially on those reported by Menendez et al.39, and then substantially modified to improve 
target specificity (Table 1).
Quantitative real-time RT-PCR of Paneth cell products. Gene-specific oligonucleotide primers 
(Tables 1 and 2) were synthesized by Invitrogen Life Technologies (Carlsbad, CA). Design of these primers used 
MacVector software (MacVector, Cary, NC), except for those in Table 1 designated as from Menendez, et al.39. 
Real-time PCR was performed using single-stranded cDNA from experimental tissues or gene-specific plas-
mids (from the standard curve described above) as templates, using the specific oligonucleotide primer pairs 
and LightCycler FastStart DNA Master SYBR Green 1 reagents (with [MgCl2] = 1 mM, final) in a thermocy-
cler equipped with a fluorescence detection monitor (Light Cycler, Roche Diagnostics, Mannheim, Germany) 
as described41. Accumulation of fluorescence signal from intercalation of the SYBR green probe into the PCR 
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products was thereby monitored cycle-by-cycle. Absolute quantification of specific mRNA from tissue was deter-
mined by extrapolation of the detection threshold (crossing point) to the crossing point for gene-specific exter-
nal plasmid standard analyzed within each run41. A negative control reaction that omitted template cDNA was 
included with each set of reactions to check for possible cross-contamination. To confirm PCR amplification of 
the intended product, melting temperature profile curves of every PCR reaction was determined at the end of 
each reaction as described41.
Statistical analysis. Error bars represent standard error of the mean. For non-parametric statistical compar-
isons of data between two groups, a Mann Whitney test was performed using Prism 8 (GraphPad Software, Inc). 
Stata version 12.1 (Statacorp, College Station TX) was used to generate principal component analyses; scree plots 
of Eigen values were generated to determine the number of components.
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